Active — Not RecruitingNot Applicable

Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group

United States57,816 participantsStarted 2010-04-30

Plain-language summary

The Children's Oncology Group has established a research network, the Childhood Cancer Research Network (CCRN), to collect information about children with cancer and other conditions that are benign but involve abnormal cell growth in order to help doctors and scientists better understand childhood cancer. The CCRN's goal is to collect clinical information about every child diagnosed with cancer and similar conditions in the United States and Canada, to allow researchers to study patterns, characteristics, and causes of childhood cancer. The information can also help researchers study the causes of childhood cancer. To expand the CCRN, parents of children who have been diagnosed with cancer will be asked to provide information about themselves and their child for research purposes.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* All patients, diagnosed with a primary malignancy since the date the initial IRB approval was received for this study with any of the following diagnoses are eligible: * All cancer cases with an ICD-O histologic behavior code of two "2" (carcinoma in situ) or three "3" (malignant). * All lesions of the central nervous system regardless of behavior, i.e., benign, borderline or malignant. * The benign/borderline conditions which will be reportable by agreement shall include: * Mesoblastic nephroma. * All teratomas, regardless of locations. * Myeloproliferative disease * Langerhans Cell histiocytosis * Patients with a secondary malignancy may be eligible provided they also meet the criteria in the above. These patients need to be enrolled using their primary diagnosis. * Participants 0 through 21 years of age are eligible; irrespective of eligibility for other COG studies. * Participant must be resident of the United States, Canada or Mexico.

What they're measuring

To collect information on children with cancer

Timeframe: After initial diagnosis

Trial details

NCT IDNCT01117168

SponsorChildren's Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2030-12-31